Protein N-terminal processing: substrate specificity of Escherichia coli and human methionine aminopeptidases.
暂无分享,去创建一个
Feiran Zhang | Jun O. Liu | D. Pei | Feiran Zhang | Dehua Pei | Jun O Liu | Qing Xiao | Benjamin A Nacev | B. Nacev | Qing Xiao
[1] Á. Furka,et al. General method for rapid synthesis of multicomponent peptide mixtures. , 2009, International journal of peptide and protein research.
[2] S. Chai,et al. Discovery of inhibitors of Escherichia coli methionine aminopeptidase with the Fe(II)-form selectivity and antibacterial activity. , 2008, Journal of medicinal chemistry.
[3] S. Davidsen,et al. Discovery, identification, and characterization of candidate pharmacodynamic markers of methionine aminopeptidase-2 inhibition. , 2008, Journal of proteome research.
[4] T. Meinnel,et al. Extent of N‐terminal modifications in cytosolic proteins from eukaryotes , 2008, Proteomics.
[5] Jun O. Liu,et al. Regulation of c-Src nonreceptor tyrosine kinase activity by bengamide A through inhibition of methionine aminopeptidases. , 2007, Chemistry & biology.
[6] Thierry Meinnel,et al. The Proteomics of N-terminal Methionine Cleavage*S , 2006, Molecular & Cellular Proteomics.
[7] Jun O. Liu,et al. Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression , 2006, Proceedings of the National Academy of Sciences.
[8] A. Curnow,et al. Serendipitous discovery of novel bacterial methionine aminopeptidase inhibitors , 2006, Proteins.
[9] D. Pei,et al. Traceless capping agent for peptide sequencing by partial edman degradation and mass spectrometry. , 2006, Analytical chemistry.
[10] F. Nan,et al. Metalloform-Selective Inhibition: Synthesis and Structure—Activity Analysis of Mn(II)-Form-Selective Inhibitors of Escherichia coli Methionine Aminopeptidase. , 2006 .
[11] F. Nan,et al. Metalloform-selective inhibition: synthesis and structure-activity analysis of Mn(II)-form-selective inhibitors of Escherichia coli methionine aminopeptidase. , 2005, Bioorganic & medicinal chemistry letters.
[12] Jun O. Liu,et al. Structural basis for the functional differences between type I and type II human methionine aminopeptidases. , 2005, Biochemistry.
[13] M. Gu,et al. Characterization of full length and truncated type I human methionine aminopeptidases expressed from Escherichia coli. , 2004, Biochemistry.
[14] T. Meinnel,et al. Protein N-terminal methionine excision , 2004, Cellular and Molecular Life Sciences CMLS.
[15] F. Nan,et al. Discovery and structural modification of inhibitors of methionine aminopeptidases from Escherichia coli and Saccharomyces cerevisiae. , 2003, Journal of medicinal chemistry.
[16] D. Egan,et al. Physiologically relevant metal cofactor for methionine aminopeptidase-2 is manganese. , 2003, Biochemistry.
[17] D. Pei,et al. An improved method for rapid sequencing of support-bound peptides by partial edman degradation and mass spectrometry. , 2003, Journal of combinatorial chemistry.
[18] K. Gevaert,et al. Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides , 2003, Nature Biotechnology.
[19] M. Doyle,et al. Steady-state kinetic characterization of substrates and metal-ion specificities of the full-length and N-terminally truncated recombinant human methionine aminopeptidases (type 2). , 2001, Biochemistry.
[20] H. Parekh,et al. A Dde-based carboxy linker for solid-phase synthesis , 2001 .
[21] M. F. White,et al. High Resolution Structure of the Phosphohistidine-activated Form of Escherichia coli Cofactor-dependent Phosphoglycerate Mutase* , 2001, The Journal of Biological Chemistry.
[22] K. Biemann,et al. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells. , 1999, Chemistry & biology.
[23] W. Bornmann,et al. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[24] K. Biemann,et al. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. , 1997, Chemistry & biology.
[25] X Li,et al. Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopeptidases. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[26] W. Zhou,et al. A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells. , 1994, Cancer research.
[27] R A Bradshaw,et al. Isolation and characterization of the methionine aminopeptidase from porcine liver responsible for the co-translational processing of proteins. , 1992, The Journal of biological chemistry.
[28] D. Ingber,et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth , 1990, Nature.
[29] J. Smith,et al. Purification and characterization of a methionine aminopeptidase from Saccharomyces cerevisiae. , 1990, The Journal of biological chemistry.
[30] P. Dessen,et al. Extent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[31] C. Miller,et al. pepM is an essential gene in Salmonella typhimurium , 1989, Journal of bacteriology.
[32] S. Chang,et al. Methionine aminopeptidase gene of Escherichia coli is essential for cell growth , 1989, Journal of bacteriology.
[33] K. Myambo,et al. Processing of the initiation methionine from proteins: properties of the Escherichia coli methionine aminopeptidase and its gene structure , 1987, Journal of bacteriology.
[34] H. Bunn,et al. Amino-terminal processing of proteins: hemoglobin South Florida, a variant with retention of initiator methionine and N alpha-acetylation. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. Stewart,et al. Amino-terminal processing of mutant forms of yeast iso-1-cytochrome c. The specificities of methionine aminopeptidase and acetyltransferase. , 1985, The Journal of biological chemistry.
[36] J. Waller,et al. THE NH2-TERMINAL RESIDUES OF THE PROTEINS FROM CELL-FREE EXTRACTS OF E. COLI. , 1963, Journal of molecular biology.
[37] R. Kaiser,et al. Enhancement of cyanogen bromide cleavage yields for methionyl-serine and methionyl-threonine peptide bonds. , 1999, Analytical biochemistry.
[38] K. Sudo,et al. Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470). , 1994, Anticancer research.
[39] Y. Mechulam,et al. Methionine as translation start signal: a review of the enzymes of the pathway in Escherichia coli. , 1993, Biochimie.
[40] Kit S. Lam,et al. A new type of synthetic peptide library for identifying ligand-binding activity , 1992, Nature.
[41] G. von Heijne,et al. Sequence determinants of cytosolic N-terminal protein processing. , 1986, European journal of biochemistry.